New Medications Being Studied

The Ambulatory Clinical Research Center offers clinical trials for a wide variety of new drugs in many areas related to musculoskeletal diseases. Active investigation is ongoing for the treatment of Rheumatoid Arthritis, Osteoarthritis, Lupus and Osteoporosis. These studies, conducted by a team of experienced rheumatologists, an endocrinologist and research nurses provide free treatment for eligible patients.

Contact:  212-598-6650

Current Research Projects:

• A Randomized, Double-Blind, Placebo-Controlled Study of Oral Alendronate Sodium 35 or 10 mg for the Prevention and Treatment of Periprosthetic Osteolysis
  
  
• Research Trial for Prevention of Loosening of Total Hip Replacement
  
  
• Trials for Osteoarthritis: A study to compare the incidence of clinically significant upper GI adverse events associated with celecoxib to that of ibuprofen in patients with Osteoarthritis (OA) or Rheumatiod Arthritis (RA).
  
  
• Trials for Osteoarthritis:Randomized controlled multi-center double-blind crossover clinical trial to compare the efficacy and safety of arthrotec to acetaminophen in patients with osteoarthritis of the hip or knee.
  
  
• Trials for Rheumatoid Arthritis: A multicenter, study comparing the incidence of clinically significant upper GI adverse events associated with elecoxib to that of ibuprofen in patients with Osteoarthritis (OA) or Rheumatiod Arthritis (RA).
  
  
• Trials for Rheumatoid Arthritis: A double-blind, placebo-controlled study of the effect of MK-0966 on blood and synovial fluid prostaglandin levels and synovial fluid MK-0966 concentrations in patients with Rheumatoid Arthritis (RA).